BOSTON, Aug 04, 2008 /PRNewswire-FirstCall via COMTEX/ ----AMICAS, Inc. (Nasdaq: AMCS), a leader in radiology and medical image and information management solutions, today reported unaudited financial results for the second quarter ended June 30, 2008.

 (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO
   ) Q2 Financial Highlights 

Revenue: Total revenues for the second quarter of 2008 were $13.6 million, compared to $12.5 million for the second quarter of 2007.

Operating Loss: Operating loss for the second quarter of 2008 was $602,000, compared to an operating loss of $1.4 million for the second quarter of 2007.

Net Loss: The Company's net loss for the second quarter of 2008 was $97,000, or $(0.00) per share, compared to net loss of $480,000, or $(0.01) per share, for the second quarter of 2007.

In the second quarter of 2008, both operating loss and net loss included $185,000 of non-cash stock-based compensation expense and $848,000 of depreciation and amortization. In the second quarter of 2007, both operating loss and net loss included $510,000 of non-cash stock-based compensation expense and $740,000 of depreciation and amortization.

Pro-forma EBITDA: Pro-forma EBITDA, a non-GAAP financial measure, was $431,000 in the second quarter of 2008 as compared to a loss of $134,000 in the second quarter of 2007.

"Pro-forma EBITDA," a non-GAAP financial measure, refers to net income, adjusted for amortization, depreciation, interest, taxes, and stock compensation expense. A reconciliation of net (loss) income determined under GAAP to pro-forma EBITDA is included below. Management believes that its pro- forma EBITDA measurement, when viewed in addition to the Company's reported GAAP results, provides an additional meaningful measure of operating performance, enabling investors to more thoroughly evaluate current performance in comparison to past performance. This information will necessarily differ from comparable information that may be provided by other companies and should not be considered in isolation or as an alternative to the Company's operating and other financial information determined under GAAP.

Cash and Cash Flow: AMICAS ended the second quarter of 2008 with a cash, cash equivalents, and marketable securities balance of $53.9 million, no long term debt, and working capital of $49.5 million. For the second quarter ended June 30, 2008, net cash provided by operations was $276,000.

Stock Repurchase: The Company repurchased approximately 6,586,000 shares of its common stock for approximately $17.1 million in the second quarter of 2008.

Fiscal Year-to-Date Financial Highlights

Revenue: Total revenues for the first six months of 2008 were $26.4 million, compared to $24.9 million for the first six months of 2007.

Operating Loss: Operating loss for the first six months of 2008 was $1.8 million, compared to an operating loss of $2.1 million for the first six months of 2007.

Net Loss: The Company's net loss for the first six months of 2008 was $564,000, or $(0.01) per share, compared to net loss of $334,000, or $(0.01) per share, for the first six months of 2007.

For the first six months of 2008, both operating loss and net loss included $618,000 of non-cash stock-based compensation expense and $1.6 million of depreciation and amortization. For the first six months of 2007, both operating loss and net loss included $1.0 million of non-cash stock-based compensation expense, and $1.5 million of depreciation and amortization.

Pro-forma EBITDA: For the first six months of 2008, pro-forma EBITDA was $464,000 as compared to $418,000 for the same period in 2007.

Cash Flow: For the first six months of 2008, net cash provided by operations was $1.3 million.

Stock Repurchase: During the fourth quarter of 2007, the Board of Directors directed the Company to initiate a $25 million stock repurchase plan. The Company repurchased approximately 6,586,000 shares of its common stock for approximately $17.1 million in the second quarter of 2008. The Company has repurchased approximately 8,568,000 shares for approximately $22.5 million in total under this program. Under a previously authorized stock repurchase plan, during 2006, the Company repurchased 4.5 million shares of its common stock for approximately $15.0 million, the total amount authorized by the Board of Directors under the prior plan.

Business Perspective

Dr. Stephen Kahane, president, chief executive officer, and chairman of AMICAS, said, "We had our best second quarter in the past several years. Bookings were solid and revenue growth was ahead of our plan. Once again, we maintained positive cash flow from operations while building our business through significant investments in both innovative research and development programs and important distribution initiatives. Similar to the last few quarters, the second quarter resulted in several large radiology groups making the decision to use AMICAS products as the basis for their automation infrastructure going forward. Over the past nine months, AMICAS has been able to sign several very sophisticated and informed radiology groups and imaging service providers. We will continue to work hard to help these new partners succeed and to make sure others follow in their footsteps. Our top-flight solutions, which include the latest in teleradiology technology, PACS, RIS, revenue cycle management, business intelligence, and zero client referring physician tools, continue to be viewed as extremely easy to install, deploy, and support. These attributes help reduce the total cost of ownership of AMICAS solutions, which can help result in very impressive returns on investment for our customers. As we have mentioned before, it is noteworthy that, despite obstacles such as DRA and other reimbursement-related pressures, these groups made the decision to take their automation support to the next level with industry leading offerings from AMICAS."

Dr. Kahane went on to say, "Our stock buyback program was very active in Q2, resulting in the purchase of over $17 million of AMICAS stock. The Company has repurchased approximately 8,568,000 shares for approximately $22.5 million in total under the $25 million program put in place in December of last year. Over the past two years, AMICAS has bought back over $37.5 million of its common stock. AMICAS has no debt and has a very strong recurring revenue base. We believe that our customers and the market recognize that AMICAS is committed to being the leading independent image and information management solutions provider in the healthcare industry. We believe that our innovative end-to-end suite of products, our strong and experienced team of professionals, and our dedicated focus on image and information management will help our customers and partners by empowering them to grow, differentiate, and efficiently run their practices and businesses in 2008 and beyond."

Dr. Kahane added, "We have entered the second half of 2008 energized, focused, and ready to work relentlessly to reach our goals and objectives and to become the leading independent vendor of choice in the image and information management marketplace."

Looking Forward

AMICAS continues to expect 2008 revenues to be between $52 million and $54 million. Pro-forma EBITDA is now expected to be approximately $1.5 million which is consistent with a net loss of approximately ($0.02) per share. AMICAS expects 2008 bookings growth of 10 to 20 percent. Bookings are defined as contractual commitments from customers for licenses, services, hardware, and maintenance/support.

Conference Call

AMICAS will host a conference call on Tuesday, August 5, at 8:30 a.m. Eastern Time to discuss the Company's 2008 second fiscal quarter results. Investors and other interested parties may dial in to the call using the toll free number 1.800.862.9098. (conference ID: 7AMICAS). The conference call will also be available via Webcast at http://www.amicas.com. Following the conclusion of the call, a replay will be available at 1.800.283.8183 or 402.220.0867 until September 4, 2008.

AMICAS, Vision Series, Vision Reach, RadStream and AMICAS Insight are trademarks or registered trademarks of AMICAS, Inc.

About AMICAS, Inc.

AMICAS, Inc. (http://www.amicas.com) is a leader in radiology and medical image and information management solutions. The AMICAS(R) Vision Series(TM) products provide a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided a fully-integrated, HIS/RIS-independent PACS, featuring advanced enterprise workflow support and scalable design. Complementing the Vision Series product family is AMICAS Insight(TM) Solutions, a set of client-centered professional and consulting services that assist our customers with a well-planned transition to a digital enterprise. HIS and RIS mean hospital information system and radiology information system, respectively.

Safe Harbor Statement

Except for the historical information herein, the matters discussed in this release include forward-looking statements. In particular, the forward-looking statements contained in this release include statements about our anticipated financial and operating results for the remainder of fiscal year 2008. When used in this press release, the words: believes, intends, plans, anticipates, expects, estimates, and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause actual results to differ materially which include, but are not limited to, the following: a significant portion of the Company's quarterly sales are concluded in the last month of the fiscal quarter; the length of sales and delivery cycles; the deferral and/or realization of deferred software license and system revenues according to contract terms; the timing, cost and success or failure of current and new product and service introductions and product upgrade releases; potential patent infringement claims against AMICAS and the related defense costs; the ability of AMICAS to comply with all government laws, rules and regulations; and other risks affecting AMICAS' businesses generally and as set forth in AMICAS' most recent filings with the Securities and Exchange Commission, including the section entitled "Risk Factors" of our most recent annual report on Form 10-K, and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this release are qualified by these cautionary statements and are made only as of the date of this release. AMICAS is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise. The financial statements and information as of, and for the period ended, June 30, 2008, contained in this press release are subject to review by the Company's independent registered public accounting firm.

 CONTACT: Colleen McCormick, Investor Relations 617-779-7892
   cmccormick@amicas.com Condensed Consolidated Balance Sheets (Unaudited) (in thousands, except share data) June 30, December
   31, 2008 2007 Assets Current assets: Cash and cash equivalents $6,353 $8,536 Marketable securities 47,527 67,071 Accounts
   receivable, net of allowances of $290 and $231, respectively 11,980 10,483 Prepaid expenses and other current assets 2,700
   3,600 Total current assets 68,560 89,690 Property and equipment, less accumulated depreciation and Amortization of $7,178
   and $6,848, respectively 1,334 1,186 Goodwill 27,313 27,313 Acquired/developed software, less accumulated amortization of
   $9,052 and $7,992, respectively 6,948 8,008 Other intangible assets, less accumulated amortization of $1,956 and $1,742, respectively
   1,444 1,658 Other assets 1,583 586 Total Assets $ 107,182 $ 128,441 Liabilities and stockholders' equity Current liabilities:
   Accounts payable and accrued expenses $6,256 $7,094 Accrued employee compensation and benefits 1,658 1,451 Deferred revenue
   11,153 10,375 Total current liabilities 19,067 18,920 Unrecognized tax benefits 1,326 1,275 Commitments and contingencies
   Stockholders' equity: Preferred stock $.001 par value; 2,000,000 shares authorized; none issued - - Common stock $.001 par
   value, 200,000,000 shares authorized, 51,405,762 and 51,296,823 issued, respectively 51 51 Additional paid-in capital 229,855
   229,056 Accumulated other comprehensive income 71 60 Accumulated deficit (99,042) (98,478) Treasury stock, at cost, 15,207,435
   and 6,824,192 shares (44,146) (22,443) Total stockholders' equity 86,789 108,246 Total Liabilities and Stockholders' Equity
   $ 107,182 $ 128,441 Condensed Consolidated Statements Of Operations (Unaudited) (in thousands, except per share data) Three
   Months Ended Six Months Ended June 30, June 30, 2008 2007 2008 2007 Revenues Maintenance and services $10,552 $9,583 $20,305
   $18,791 Software licenses and system sales 3,023 2,919 6,058 6,144 Total revenues $13,575 $12,502 $26,363 $24,935 Costs and
   expenses Cost of revenues: Maintenance and services (a) $4,692 $4,194 $8,961 $8,186 Software licenses and system sales, including
   amortization of software costs of $571, $476, $1,060 and $979, respectively 1,731 1,670 3,942 3,189 Selling, general, and
   administrative (b) 5,282 5,480 10,284 10,857 Research and development ( c ) 2,195 2,278 4,390 4,300 Depreciation and amortization
   277 264 552 536 14,177 13,886 28,129 27,068 Operating loss (602) (1,384) (1,766) (2,133) Interest income 572 930 1,361 1,887
   Loss on sale of investments - - (31) - Loss before provision for income taxes (30) (454) (436) (246) Provision for income
   taxes 67 26 128 88 Net loss $(97) $(480) $(564) $(334) Loss per share Basic: $(0.00) $(0.01) $(0.01) $(0.01) Diluted: $(0.00)
   $(0.01) $(0.01) $(0.01) Weighted average number of shares outstanding Basic 40,740 44,568 42,188 44,559 Diluted 40,740 44,568
   42,188 44,559 (a) - includes $35,000, $27,000, $70,000, and $48,000 in stock-based compensation expense for the three and
   six months ended June 30, 2008, and June 30, 2007, respectively. (b) - includes $50,000, $0.4 million, $0.3 million, and $0.9
   million in stock-based compensation expense for the three and six months ended June 30, 2008, and June 30, 2007, respectively.
   ( c ) - includes $100,000, $71,000, $213,000, and $133,000 in stock-based compensation expense for the three and six months
   ended June 30, 2008, and June 30, 2007, respectively. CONDENSED Consolidated Statements Of Cash Flows (Unaudited) (in thousands)
   Six Months Ended June 30, 2008 2007 Operating activities Net loss $(564) $(334) Adjustments to reconcile net loss to cash
   provided by operating activities: Depreciation and amortization 552 538 Provisions for (recoveries from) bad debts 110 (341)
   Loss on disposal of fixed assets 6 - Amortization of software development costs 1,060 979 Non-cash stock compensation expense
   618 1,034 Changes in operating assets and liabilities: Accounts receivable (1,607) (52) Computer hardware held for resale,
   prepaid expenses, and other 904 854 Accounts payable and accrued expenses (630) 922 Deferred revenue including unearned discount
   778 993 Unrecognized tax benefits 50 46 Cash provided by operating activities 1,277 4,639 Investing activities Purchases of
   property and equipment (492) (264) Purchase of software - (2,300) Purchases of held-to-maturity securities (189,410) (44,592)
   Maturities of held-to-maturity securities 175,642 44,174 Purchases of available-for-sale securities (5,597) (13,587) Sales
   of available-for-sale securities 37,919 15,240 Cash provided by (used in) investing activities 18,062 (1,329) Financing activities
   Repurchases of common stock (21,703) - Exercise of stock options 181 182 Cash (used in) provided by financing activities (21,522)
   182 Increase (decrease) in cash and cash equivalents (2,183) 3,492 Cash and cash equivalents at beginning of period 8,536
   7,331 Cash and cash equivalents at end of period $6,353 $10,823 Supplemental disclosure of cash paid during the period for:
   Income taxes, net of refunds $115 $60 Non-cash investing activities: Unrealized gain (loss) on available-for-sale securities
   $11 $(29) 2008 Projected Reconciliation of projected net loss to projected EBITDA Projected net loss $(900) Interest income
   2,300 Operating loss (3,200) Non-cash stock compensation expense 1,400 Depreciation and amortization 1,100 Amortization of
   software development costs 2,200 Projected pro-forma EBITDA $1,500 Reconciliation of net (loss) income to EBITDA Three Months
   Ended Six Months Ended June 30, June 30, 2008 2007 2008 2007 Net loss $(97) $(480) $(564) $(334) Provision for income taxes
   (67) (26) (128) (88) Interest income 572 930 1,361 1,887 Loss on sale of investments - - (31) - Operating loss (602) (1,384)
   (1,766) (2,133) Non-cash stock compensation expense 185 510 618 1,034 Depreciation and amortization 277 264 552 538 Amortization
   of software development costs 571 476 1,060 979 Pro-forma EBITDA $431 $(134) $464 $418 

SOURCE AMICAS, Inc.

http://www.amicas.com/
   

Copyright (C) 2008 PR Newswire. All rights reserved **********************************************************************
   As of Thursday, 07-31-2008 23:59, the latest Comtex SmarTrend� Alert, an automated pattern recognition system, indicated an
   UPTREND on 04-07-2008 for AMCS @ $2.56. For more information on SmarTrend, contact your market data provider or go to www.mysmartrend.com
   SmarTrend is a registered trademark of Comtex News Network, Inc. Copyright � 2004-2008 Comtex News Network, Inc. All rights
   reserved.